Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Market Cap	113.47B
Revenue (ttm)	69.49B
Net Income (ttm)	5.32B
Shares Out	97.90M
EPS (ttm)	54.29
PE Ratio	21.35
Forward PE	n/a
Dividend	10.00 (0.86%)
Ex-Dividend Date	Apr 14, 2025

Volume	12,465
Average Volume	34,200
Open	1,151.05
Previous Close	1,160.03
Day's Range	1,121.11 - 1,160.00
52-Week Range	691.00 - 1,310.00
Beta	0.10
RSI	74.29
Earnings Date	Aug 26, 2025

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; AND import and marketing of nutritional products. It imports and markets diagnostic equipment, molecu...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1888
• Employees: 1,406
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: ABOT

Financial Performance

In 2024, PSX:ABOT's revenue was 68.18 billion, an increase of 22.90% compared to the previous year's 55.48 billion. Earnings were 5.23 billion, an increase of 1899.50%.